text:
Whether through food or facilities, we create campuses that engage and attract college students.
Do you have a dream for your campus? Maybe it's to introduce a new locally grown dining concept in your student center. Maybe it's to manage cleaner, more sustainable campus facilities. Maybe it's just to better understand what students are excited about today.
From facilities to food services, we know what college students want and we use that knowledge to create the ultimate campus experience. It's what makes us the preferred partner for outsourcing in higher education.
¹Stat Source: Society of College and University Planners, Planning for Higher Education V41N1, Assessment and the Outdoor Campus Environment: Using a Survey to Measure Student Satisfaction with the Outdoor Physical Campus
Students are seeking healthy, great-tasting food in dynamic environments.
Clean, sustainable and innovative living and learning spaces are important to you and your students.


text:
Reviewed By ronald w (Litchfield, IL) Reviewed for a 2015 Ford F-150 —8/19/2016 4:41 AM
works great
Reviewed By Lisa S (Wakefield, RI) Reviewed for a 2010 Ford F-150 —9/14/2014 5:29 PM
I bought this for my husband as he has just recently started biking. It's so convenient and easy to use. Just back the bike into the slot and off you go. No more using tie downs. We've had 3 bikes in it so far and I'm sure 4 will fit just fine.

subset: commoncrawl


text:
Is it possible to encode mp4 video with the original DVD chapters built into them so the PS3 will recognise the original chapters. Or does PS3 not support chapters like this? Am I stuck with the 1/2/5 minute chapters the PS3 creates itself?
I've done a bit of digging but dont seem to be able to find any recent info on this


text:
View More: Wizard of Oz Costumes
He's the man soon to become the Wizard of Oz! When you want to show the world your favorite storybook series! With James Franco playing him, what's not to like? Grab our Wizard of Oz Oscar Diggs Costume today!When you want to take a trip to Oz, this is the perfect style for you! Don't go for second best, pick up our Wizard of Oz Oscar Diggs Costume today!
Available in Sizes:
Small, Standard and XL
Item Includes:
Jacket with Attached Shirt, Vest, Bow-Tie, Pants and Hat
Pictured items not included:
100 % Polyester Exclusive of Trim
Care Instructions:
Hand Wash in Cold Water w/ Mild Detergent or Shampoo - AIR DRY
Licensed by:
Wizard Of Oz
Your rating was successfully saved, and is pending approval. Thank you!
Your rating was successfully deleted.
Be the first to write a review
This product has no customer reviews.
Size Chart For:
Wizard of Oz Oscar Diggs Costume - Mens


text:
Career Development
The Office of Career Development is committed to helping Salve Regina students reach their career goals. We can assist students with deciding on a major, exploring career options, applying for internships, implementing a successful job search and much more. Our career advisers are available to meet with students during one-on-one appointments and daily drop-in hours, and we also host a variety of targeted career workshops throughout the academic year.
The Salve Regina Gateway provides resources and services to help students plan their careers and find employment opportunities. Students can search and apply for student employment, part-time and full-time jobs and internships, and sign up for career workshops, on-campus interviews, employer information sessions and career fairs.
Gateway houses several exclusive resources, including Spotlight on Careers, the Internship Series, CareerSearch, Internships.com and the Do What You Are self-assessment tool. Students may also schedule an appointment with a career adviser through Gateway.


text:
Hours: 9 a.m.-5 p.m. Mondays-Saturdays and 9 a.m.-4 p.m. Sundays during the season
Contact: (573)374-1417
What's hot now: Summer may be winding down, but...
Hours: 9 a.m.-5 p.m. Mondays-Saturdays and 9 a.m.-4 p.m. Sundays during the season
Contact: (573)374-1417
What's hot now: Summer may be winding down, but now is the time to find some great deals. Plus as we head into fall, the market offers an assortment of fun outdoor items for autumn and Halloween, including pumpkins, mums, scarecrows and witches.
With more than 16 years of business at the Lake of the Ozarks, Sunrise Farm Market has evolved from a simple fresh fruit and vegetable stand to one of the best reasons to visit the Westside with its array of fun yard art and other unique finds.
The seasonal roadside business at 14539 N. State Highway 5 in Sunrise Beach offers outdoor items that you won't find in any box store — or anywhere else in the lake area for that matter. Co-owner Bess Wood says if it's going to be sold somewhere else in the area, she doesn't buy it for the store so that she can offer truly unique items.
The two open air buildings that make up the main part of Sunrise Farm Market pop with the profusion of color from the many fun and quirky decorative items alongside the vibrant hues of summer-fresh fruits and vegetables.
From metal flying pigs, roosters and signs to chimineas, pottery and arbors and much more, if you shop at Sunrise Farm Market, your yard and gardens are sure to stand out.
And that's in addition to their food products. The market offers local fruits and vegetables — some of the juiciest tomatoes around — as well as pies homemade by Mennonites in the region and other specialty food products.
There are no similar businesses or products to compare to Sunrise Farm Market, says Bess. She and husband Mike decided to open a business at the lake after doing home and garden shows and trade shows for some time.
Mike is originally from the lake, growing up in Osage Beach.
With Sunrise Farm Market, they got to offer the home and garden items and fruits all in one place for the summer.
Local honey
For those who believe that local honey helps with allergies, Sunrise Farm Market also sells honey from a Missouri bee farm. In addition to allergies, it is a natural sweetener and energy booster. It's unique taste adds a special touch to recipes, but you can also use it to boost your own beauty and skin care products. According to the National Honey Board, honey is a humectant - naturally attracting and retaining moisture. Add a squeeze of honey to your regular moisturizer, soap or shampoo for extra moisturizer or use as a base to to create your own. Honey also has natural antimicrobial qualities and has been used for centuries as a natural cough suppressant.
Location, ST | website.com


text:
Sturm, Ruger expected to 31.6% jump in earnings
Wall Street is high on Sturm, Ruger RGR +3.34% (RGR), expecting it to report earnings that are up 31.6% from a year ago when it reports its first quarter earnings on Monday, April 29, 2013. The consensus estimate is $1.04 per share, up from earnings of 79 cents per share a year ago.
Post a comment
You must sign in before you can post comments. If you are experiencing issues with your account please e-mail firstname.lastname@example.com.


text:
Uncle Sam rewards NH's worst schools with $1.4M
WASHINGTON, Aug. 26 (UPI) -- New Hampshire, Idaho and Hawaii will share $5.2 million in their work to turn around lowest performing schools, the U.S. Education Department announced Monday.
Post a comment
You must sign in before you can post comments. If you are experiencing issues with your account please e-mail email@example.com.


text:
Center for Minimally Invasive Esophageal Therapies
Photodynamic Therapy
The Center for Minimally Invasive Esophageal Therapies at Boston Medical Center is, first and foremost, here to serve you and your family. We are a team of dedicated specialists whose common goal is to treat your cancer and lead you on the path to recovery in as comfortable a way as possible. You will be treated in state-of-the-art facilities using a multidisciplinary approach. Our staff of compassionate diagnosticians, surgeons, physician assistant, nurse practitioners, and surgical nurses work collaboratively to provide you with the most advanced and effective medical treatment in New England—as well as unmatched patient care.
Photodynamic therapy (PDT), also called photoradiation therapy, phototherapy and photochemotherapy, has existed for about 100 years and is a type of cancer treatment that uses light to kill abnormal cells. A special drug called a photosensitizer or photosensitizing agent is circulated through the bloodstream.
After the agent has been absorbed by the cancer, usually over a period of a few hours to a few days, depending on the drug used (this is called the drug-to-light interval), the tumor is exposed to a special kind of light. The light and the agent create an active form of oxygen that destroys cancer cells. PDT is thought to potentially also destroy tumor-feeding blood vessels and stimulate the immune system to attack the cancer cells.
PDT is currently approved by the Food and Drug Administration to treat or relieve the symptoms of esophageal cancer. A handful of photosensitizers are approved, and we will determine the best one for you, depending on your specific diagnosis. PDT light sources range from laser and pulsed light to blue light and red light.
PDT is a promising treatment for certain types of tumors because, in some cases, it can cure cancer. It is also less invasive and quicker than surgery and other procedures, leaves little or no scarring and has no long-term side effects, can be targeted very precisely to cancerous cells, and can be repeated many times at the same site.
Treatment can make your eyes and skin especially sensitive to light for six weeks or so, however. We recommend avoiding direct sunlight and bright indoor light during this period. Because the basis of phototherapy is light, its treatment is limited to areas on or just below the skin. Newer, more sophisticated photosensitizing methods are in development.
Side effects are rare, but may include:
- Burning, swelling, or pain on or below the skin's surface
- Coughing
- Trouble swallowing
- Painful breathing
- Shortness of breath
How to Prepare
It is important to follow any instructions given to you by your physician to prepare for surgery.
What to Expect
Each session of PDT is relatively simple. You can expect to arrive and receive either a photosensitizer drug then and wait a few minutes or hours until it has concentrated in the tumor, or you may visit us to have the drug administered and return days later for phototreatment.
For phototreatment, you will lie on a comfortable examination table, and an anesthesiologist will administer local or general medicines to control pain and relax you. Then we will activate the appropriate type of light over the tumor in a strong, targeted beam. The procedure may take a few minutes or up to two hours.
Recovery from PDT is typically quite easy. You may experience some dryness or mild burning on the skin, but other effects are uncommon. Gentle skin products such as Vaseline can be helpful. Avoid the sun, as your sensitivity will be increased for a time following PDT; even a few minutes of sun exposure can sometimes cause discomfort. Please follow your doctor's instructions regarding medications and physical activity, but most likely you will be able to return to your normal activities right away.
Other Treatments
Our Team
Patient Information


text:
EAGLE COUNTY, Colorado - A lot of local residents are getting an unpleasant surprise when they receive their first homeowner's insurance bills for the year - higher premiums.
Not everyone is getting bigger bills - some homeowners are actually seeing premium decreases this year - but some property owners are being dropped by their insurance companies. The reason, at least in part, is the destructive wildfires that hit the state's Front Range last year.
Those fires resulted in an estimated $538 million in property losses. A big part of that total was covered by insurance, and several companies writing claim checks took some serious hits to their bottom lines.
Patty Hood runs the Hood Insurance Agency in Eagle. That company is an independent agency, which means Hood represents several insurance firms. Hood said the companies she represents haven't raised rates to her clients this year. But, she said, other insurance companies - especially those that insured a lot of homes where the wildfires did the most damage - were hit hard.
Insurance companies need to have cash reserves on hand to pay claims, Hood said. When those reserves are depleted, they're often replenished with higher premiums to customers.
Kelly Hollis, an agent at the Eagle-based Montag Group, said she's seen, and heard about, a lot of premium increases.
"Risk is spread across a state," Hollis said, adding that Front Range hail storms have in the past affected auto insurance rates on the Western Slope.
The Montag Group represents Farmers Insurance, and Hollis said homeowner's insurance rates have gone up in the neighborhood of 10 to 20 percent. Some companies have stopped writing new policies altogether, and others aren't renewing existing policies.
But it isn't just wildfires or hail storms that drive rates.
Noel Harris, owner of Wall Street Insurance in Edwards, said there are a lot of factors that drive rates. But the bottom line is that insurance companies are in business to make money. That means companies need more revenue coming in than they pay in claims.
Harris said good companies will budget roughly 40 percent of their premium revenue to cover losses, with about 50 percent for expenses, leaving roughly 10 percent for profit.
When that formula is out of whack - usually due to unusually high losses - insurers need to adjust.
"With wildfires, companies with a lot of exposure had significant claims, and their loss rates went to 60 or 70 percent," Harris said.
For national companies, heavy losses can happen just about anywhere. Hurricane Sandy last fall is driving at least some rate increases in Colorado, Harris said.
Other factors in setting rates can range from whether a homeowner has a fire-suppression sprinkler system to a person's credit rating.
So what can a homeowner do?
Hollis suggested some customers might want to increase their deductibles - the amount of money a homeowner has to pay before the insurance company pays on a claim.
Harris advised homeowners to think carefully before filing a relatively minor claim. If someone has a $2,500 deductible, it doesn't make sense to file a claim for a $2,600 loss, he said.
But rates ultimately boil down to models the companies have, Harris said. The right improvements to a home in the right neighborhood can actually save some money come policy renewal time.
"We've seen rates for some people go down 10 to 12 percent," he said.
Business Editor Scott N. Miller can be reached at 970-748-2930 or firstname.lastname@example.com.


text:
Related Stories
In Jason Newsted's storied career, he has worked with some of the biggest names in heavy metal. Here are his favorite tracks (all of which he performed on):
"Sad but True," by Metallica (from 1992 album "Metallica.")
"Hatred Aside" by Sepultura (from 1998 album "Against.")
"The Getaway," by Voivod (from 2006 album "Katorz.")
"Out of My Mind," by Who Cares (from 2011 album "Tony Iommi & Ian Gillan: Who Cares?")
"Soldierhead," by Newstead (from 2013 album "Metal.")


text:
Luxury Studio with washing machine for 4 people in Copacabana C046
Спальные места4
Ванные комнаты1
Площадь45 м²
Этаж №10(с лифтом)
- Возможность проживания семьи/детей
- Интернет
- Кухня
- Кондиционер
- Лифт в здании
- Полотенца
- Стиральная машина/сушилка
|Rua Bolivar, 22061-020 Rio de Janeiro, Бразилия
|Тип жилья
|ID жилья
|Процент подтвержденных запросов брони
|< 50%
|Время ответа
|Несколько часов
|Календарь обновлен
Our calenders and prices are always updated.
It is not necessary to verify the availiability and rates with us before sending your reservation request.
We do work with minimum rental periods for some events, like the Carnival, the New Years Eve and the World Cup. Please send us a message before making the reservation, if your request includes one of this events.
We administrate more than 150 vacation rental properties in the South Zone of Rio de Janeiro.
You are welcome to visit our profile to visualise all our accommodations.
Luxury Studio with 45m², divided in living room, bedroom, bathroom and a modern open kitchen with a dinette and a small service area.
The silent bedroom comes with a double bed, air conditioner, a closet and a bedside table.
The spacious living room provides a pull out sofa for two people, ventilator, LCD TV, a dolby surround system and a DVD player.
The dropped ceilings with indirect lightnings provide a pleasant atmosphere in the rooms.
The property is equipped with free wireless Internet and cable TV.
Located silently in the 10th floor of a safe and well administrated building with 24h doorman.
Great Location! Only 5 minutes distance to the Underground Station Cantagalo and the famous Copacabana beach.
For your safety and convenience, we offer a transfer by executive car, with a bilingual driver. If interested, please request more information by sending a message.
We hand over the apartment clean and in perfect condition, including bed and bath linen. Is also our responsibility to clean the property and to take care of bed and bath linen laundering when client leaves.
Extra cleaning:
If the client wants an extra cleaning during his stay in the property, we just need to schedule according to availability of dates and times.
For any extra cleaning will be done the exchange of bed and bath linen. Price: R$60 (BRL)
Reservation confirmation:
To validate your reservation, we require the following information:
Passport or ID number
Phone number
E-mail address
Check-in time & Flight number (for plane arrivals)
Checkout time
Names of occupants
Reservation / rental cancelation and changing of booking dates/times
Office times:
Monday/Friday – 8am to 7pm
Saturday/Sunday/Holidays – 9am to 4pm
Out of our office times we have a employee and a 24h emergency number.
Check-in / Check Out:
Out of our office times, the customer must inform the Agency about the exact arrival time at the apartment, since our employee will meet the customer at the apartment.
Before check-in / after check-out, customers are permitted to leave luggage during regular office hours.
Check-in time is at 14h (2pm)
Check-out time is at 11h (11am)
If the customers would like to schedule a different time and the apartment is still available (Important: Please check availability and confirm before the reservation), the following fees are will be charged:
Before 6h => previous day room rate + R$ 50,00 service tax;
6h01 to 13h59 => earlier check in = 50% of room rate;
After 22h00 onwards => R$ 50,00 service tax late (late check-in);
Before 6h => R$ 50,00 service tax (early check out);
11h00 to 22h00 => 50% room rate price;
22h01 => 50% room rate price + R$ 50,00 service tax (late check- out) ;
Property Inspection
During the check-in and the check-out a company represent will come to the apartment in order to check it for any damages and return the security deposit to the customer.
This process may take 15-30 minutes depending on the size of the apartment.
Number of guests
It is forbidden to exceed the indicated number of person. Children under 1 year of age are not calculated.
Please check the allowed number of persons before renting the apartment.
Building rules
The client is fully responsible for the property and all items in the property and building.
The client and all apartment occupants and visitors must comply with the building regulations.
Fines imposed by the building administration for infringing regulations must be paid immediately by the client and can cause premature termination of the rental contract without any refund.
Please verify before making a reservation, if the building accepts the entrance of visitors.
Please advise us before making a reservation if visitors are requested and we will provide a suitable property.
If the reserved property has an internet connection or cable TV, we assume no responsibility for connection problems and any resulting damages.
This service is provided by telecommunication companies beyond our control: should there be any problems, there will be no refund of rental payments.
|Цена за неделю
|36461 руб.
|Цена за месяц
|91673 руб.
|Максимальная продложительность визита
|3 месяцев
|Заезд после
|Заселение до
|По договоренности
|Отъезд до
|Политика Отмены Брони
The host cancelled the booking, this review is automated.
Perfect place!
Everything organized super professional. Nice and very helpful stuff + perfect location - just 3 mins from Copacabana, 2 supermarkets just around the corner. Restaurant just next to the entrance. Recommended to anyone.
the security guy was not very friendly but that the only minus I can think about and nothing too serious.
We have stayed there 4 boys (friend trip).
Too small for two people! Too noisy!
Very noisy - the situation is good.
The apartment was just how we imagined it.Heidleberg provided good and smooth service, can really recommend to the next guests!
The staff at Heidelberg helpful and professional throughout our stay in Rio. They are friendly and have genuine interest in their customers. More importantly for us they also speak English which made everything much easier for us. The apartment was as advertised. A few interruptions with wi fi access but otherwise everything was great.
Very basic, but I guess its justified by the price; looked clean, wifi worked properly. Lukewarm water (not hot) but I didnt care. What I didnt appreciate was that I could hear everything happening in my neighbours kitchen and toilet - the window in my bathroom was somehow connected to theirs bathroom? Also a noisy dog wasnt fun early in the morning. Except that everything else was fine - nothing great (maybe except great location) and nothing terrible either.
We stayed at this studio flat from 14th to 18th Nov. The apartment is a little bit outdated, need some improvement on the kitchen and bathroom. But apart from that it is spacious ( the bedroom and living room) and reasonable clean. The location is excellent, just a few blocks from the beach and near a 24 hours supermarket. I would recommend this studio to anybody. I would stay again if they accept pets.
Very nice location, just 5 min. away from Cantagalo. 2 Blocks from Copacabana.
Our Agent, Bernard, who did the check in was very nice too.
The appartment itself was nice too. nice kitchen with quite qood equipment for cooking. really liked it.
The appartement was nice and clean and we had no problems except once with the door lock. But after we called it was fixed within 2 hours, which is fast in rio :)
The location was great, 1block from the beach and 2 blocks from the subway station.
The agency was serious and uncomplicated.
I can definitly recommed this appartement for 2 or 3 people since the small beds in the second bedroom just limited comfortable are.
- Гарантировать качество жилья
- Проверить каждого принимающиего Вас хозяина по телефону
- Обеспечить безопасную оплату через шифрование на базе SSL


text:
Intervention in Syria
Published: Wednesday, September 18, 2013 at 12:01 a.m.
Last Modified: Tuesday, September 17, 2013 at 10:37 p.m.
One of the arguments I hear in support of our bombing Syria in response to the use of chemical weapons there is, "We can't turn a blind eye" to the use of these truly horrific weapons. [The U.S. has reached an agreement with Russia, on Syria's behalf, to remove the chemical weapons, but bombing remains as President Barack Obama's fallback plan.]
Of course we can. We turned a blind eye to Syrian President Bashar al-Assad's father's regime when he used chemical weapons on the town of Hama and the surrounding region. We not only turned a blind eye to Saddam Hussein's Iraq when he used chemical weapons on Iranian troops in the 1980s, but we helped Saddam get the supplies needed to make them (along with intelligence on Iranian troop movements).
We're not going to get the backing of the international community, and our efforts there seem to be directed to providing us with political cover, just like with Iraq in 2003. Most of the American people are against the idea of intervention, and our elected leaders seem to be finally listening to us in this regard.
Sanctions, yes. Aid to the rebels, perhaps. But bombing teaches only one lesson — that it's OK for the nation you bombed to retaliate against you.
Winter Haven
Reader comments posted to this article may be published in our print edition. All rights reserved. This copyrighted material may not be re-published without permission. Links are encouraged.


text:
Volvo FH
Volvo FMX
Volvo FM
Volvo FE
Volvo FL
Lessen the time a driver needs to look away from the road and you reduce the risk of an accident – this has been the thinking when designing the instrument cluster in the new Volvo FH. It's led to greater flexibility in the cluster and fewer visual distractions.
"The Volvo FH is first with neck-tilt. It's the steering wheel that's the secret"
"The driver or operator can simply rearrange the positions of several of the buttons, so that the most frequently used features are closest to hand," says Nina Theodorsson. The fixed buttons have mostly been placed close to the area they control. There are buttons in the door for the windows and side mirrors, and in the ceiling for the yellow flashing light, microphone and so on. "These are in the places you are most likely to look for them," says Nina Theodorsson. "Altogether these changes contribute to a safer workplace for drivers and less damage to the truck." "Now driver's can keep their eyes where they should be – on the road."
Tall or short, narrow or wide, every driver will be able to find a comfortable working position. The new driving seat has better cushioning and is more versatile. It's the steering wheel that's the secret. With neck-tilt, a feature that evokes luxury associations, the steering wheel can be tilted, not just raised or lowered as before. "When your arms drop down a bit the driving improves," says Peter Johansson, design engineer at Volvo. Together with raising and lowering functions, the wheel can be angled up to 40 degrees – 10 of these come from the neck-tilt function. A more vertical steering wheel makes the Volvo FH feel similar to a conventional car.
Tall drivers in particular will appreciate the increased adjustment area of the driving seat. The seat can slide back further in the new Volvo FH, 4 centimetres to be precise. Altogether the seat can slide up to 24 centimetres in a forwards backwards direction (best in class). The span for raising or lowering the new seat is 10 centimetres.
The seat also has a new shape. Among other things, it has improved lateral support and longer leg support. But this is a tricky area: too little leg support is not good, too much is no good either as it makes it harder to get in and out of the seat. "The new seat is quite amazing when you realise it's designed to work for almost every shape and size of driver," says Peter Johansson.


text:
rogerfederer.com - The secret's finally out!
Navigation mit Access Keys
- [Alt + 0] - Startseite
- [Alt + 1] - Navigation
- [Alt + 2] - Inhalt
- [Alt + 3] - Kontakt
- [Alt + 4] - Sitemap
- [Alt + 5] - Suche
The secret's finally out!
It's official: I'm the new ambassador for Moët & Chandon.
Yes, the secret's finally out! I am teaming with Moët & Chandon as their new brand ambassador. Not just any champagne but the world's most loved. This is a real honour, and as a partnership, I see it as a natural match. The House of Moët & Chandon is an absolute legend, one of the most iconic symbols of global success and style.
We immortalized this celebratory moment with the camera of the amazing photographer Patrick Demarchelier. I must have been shot so many times before, but I think you'll agree these pictures are exceptional. The way Patrick has captured my movement is phenomenal.
I look forward to toasting with you my upcoming victories!
You can watch the interview with Roger here.
See photos on moet.com (plus more to come!)
I do hope, people will not associate you merely with alcohol.
Your look astonishing!
I do hope, people will not associate you merely with alcohol.
Your look astonishing!
Here's a toast to you and your long relationship with Moet. Take care and you are the very best in the world.
I'm speechless.
Keep wondering if the Lord could ever create a wonderful handsome generous gorgeous human like you!
I don't think he would want to!The universe hasn't recovered from the ecstasy of experiencing the first one yet!
I love you.
God Bless.


text:
CORPUS CHRISTI – Incarnate Word scored two second-half goals in a span of 4:05 to pull past the Texas A&M-Corpus Christi women's soccer team in a 3-0 victory on Friday at Dugan Stadium. Audrey Baldwin made 11 saves in a losing effort for the Islanders.
"Today's result was very difficult because it was so uncharacteristic of this group," head coach Shanna Caldwell said. "We were very late reacting to the play and just missing effort across the board. We had some individuals play well but we need to be playing as a whole unit.
"I think it does say a lot about our team that we went this deep into the season without having this type of game," she added. "From here we bounce back and the team has to regroup and be ready to go on Sunday at Lamar."
The Cardinals held the advantage in play early, but Baldwin was able to keep the visitors off the scoreboard until the 24th minute. That was when UIW opened the scoring with Sarah Flores converting for her third goal of the season. An Islanders defender tried to play a ball back to Baldwin, but Flores was able to beat the keeper to the ball, used a touch to get past her and put it into the back of the net at 23:43.
The score remained that way until halftime, and the Islanders came out with a spark, as Jenny Hwang had a strong opportunity in the 50th minute, but was denied by Kowalik. The Cardinals countered, and Flores sent a long ball deep in the air to a streaking Katie Miller, who went 1-v-1 with Baldwin and was able to send it into the right-hand corner of the net to make it 2-0 at 49:52.
Incarnate Word added to its advantage just over four minutes later. Abigail Koenigs worked the ball down the left side and sent a ball toward the box. There, Sydney Solomon was able to let loose a shot and beat a diving Baldwin to the left side to make it 3-0 at 53:57.
The Islanders will hit the road next with a contest at Lamar on Sunday in Beaumont. The game is scheduled to kick off at 1 p.m. For in-game updates, be sure to follow the official Twitter feed of Islanders Soccer, @IslandersSoccer.


text:
N +28º 19' 53.68" / W -81º 32' 16.08"
Tel: (1) 407 9647000Fax: (1) 407 9647001
Check-in after 16:00h
Check-out until 11:00h
Old world charm meets new world design and contemporary comfort at Meliá Orlando Suite Hotel. Wild orchids grace tabletops and large-scale impressionist paintings combine with mosaic walls, setting an atmosphere that is both European and American Chic. This all-suite accommodations near the Walt Disney World® Resort, Meliá Orlando Suite Hotel is an oasis located in one of Forbes Magazine's Top ten "Prettiest Neighborhoods" – the cozy town ofCelebration; the town that Disney built.
A world class staff is ready to help get you to and from any of the surrounding parks – the Walt Disney World® Resort , and other theme parks like Universal Studios Orlando, and Sea World – or simply help you make a reservation to a nearby wine tasting. For those looking for a Florida Golf Vacation, the Celebration Golf Course, with its immaculate landscaping and lush greens will have you ready to tee off in no time. First class food, fun in the sun, and all ofFlorida's finery are ready to greet you upon your arrival.


text:
RICHMOND -- The lithe, tattooed body reposed in an open white casket adorned with red flowers. Friends, relatives and clergy described a man who loved his family and respected his elders, liked fast cars and playing sports.
"Vincent had a heart," Cochise Potts, a pastor and family friend, told mourners at Olivet Institutional Missionary Baptist Church in Oakland on Wednesday. "He had a heart."
Vincent Demarlo Jones, who was shot and killed in Oakland on Oct. 26, had a heart but also an infamous criminal past and a reputation as one of the most fearsome gang members in Richmond in the mid-2000s, where he once was the city's "Most Wanted" fugitive. He went by the moniker "V.I."
"V.I. was one of the big ones," said Richmond police Lt. Bisa French. "Back in 2005, he was one of those guys who comes around once in a while and is seemingly into everything, they kind of blow up for a brief period. Small groups of people can account for a lot of gun violence."
Family say Jones was working hard to turn his life around since being released from prison in August after serving more than five years on federal firearms charges. His mother, sister and several cousins described him as a loving man devoted to his family. They said that since his release, he had served as a father figure to his girlfriend's daughter.
Jones was killed while walking to work in the pre-dawn hour, moments after leaving the federal halfway house where he had been paroled.
His death wasn't just a tragedy to his friends and family and an item in the next day's news, it was the subject of a departmentwide memo distributed within the Richmond Police Department.
"We did notify officers of him being killed in Oakland because we wanted them to be aware that this may spark retaliatory shootings in Richmond," French said.
Born in Martinez in 1985, as a teenager Jones became known as a member of a street gang known as "the 20s," so named for the south Richmond neighborhood where streets number from 20 to 29. The gang is affiliated with the better-known Easter Hill Boys, named for a housing project that became notorious for crime in the 1980s before being bulldozed and rebuilt.
In the unrelated murder trial of Joe "Fatter" Blacknell in February, Richmond Det. Christopher Llamas testified as a gang expert that "V.I." was a respected street leader who helped forge a lasting alliance between south and north Richmond neighborhoods against rivals in central Richmond.
When he was 16, Jones was convicted as an adult for carjacking and sentenced to more than two years in prison. He was paroled in October 2004, according to records with the state Department of Corrections.
Jones was sent back to prison twice for parole violations before October 2004.
It was between May 2005 and October 2005 that a spate of gang-related shootings put the city on edge. Then-police Chief Terry Hudson called Jones the department's "top priority," and other police officials labeled him a "street terrorist" during an unusual media campaign to hasten his arrest.
Like several young men who grew up in Richmond's neighborhood wars of recent decades, Jones and Blacknell reached an almost mythic status among their street brethren, slightly-built, heavily-armed teens, seemingly ubiquitous in dispensing mayhem.
Amid the hysteria of the summer of 2005, a beleaguered Hudson held up Jones as the worst-of-the-worst.
Police arrested Jones in October 2005 after a car and foot pursuit, cornering him with a police dog. State parole agents and the U.S. marshals were also in on the manhunt.
But despite all the public proclamations that Jones was a "violent enforcer" responsible for multiple killings and nonfatal shootings, he was only convicted of federal firearms violations, and sentenced to 77 months in prison in early 2007. Part of his sentence included that he would not be paroled back to Richmond.
Authorities said Jones had been residing at the halfway house in Oakland since August after his release, and had a job working at a local thrift store.
His killer chased him a short distance before shooting him, police said.
Police responded to reports of shots fired about 5:41 a.m. They found Jones shot alongside his apartment complex in the 400 block of Vernon Street. He was pronounced dead at the scene.
Oakland police Sgt. Johnna Watson said investigators were following leads but declined to say whether they had suspects.
More than 200 mourners, many in tears, packed the purple and white worship hall for Jones' memorial. Few nods were made to Jones' past, but some loved ones said much of Jones' reputation was built on myth and misinformation.
Meanwhile, police cars, some marked, others all black, circled outside.
Richmond has seen a steady drop in crime since the days when Jones was on the streets. When the city had declared Jones its "Most Wanted" fugitive in September 2006, there had already been 29 homicides that year, many in broad daylight.
There have been just 15 homicides in Richmond this year, a far cry from the 40-plus annual totals of the mid-2000s.
But in the days following Jones' death, shots crackled in several parts of the city. Police responded but found no one injured.
"We don't know if the shootings reported around town are associated with (Jones') death," French said.
Jones was Oakland's 105th homicide this year.
Contact Robert Rogers at 510-262-2726 or firstname.lastname@example.com and follow Twitter.com/roberthrogers


text:
JAMA is an international, peer-reviewed, general
medical journal that is distributed to readers in more than 140 countries.
Manuscripts should be submitted online via the JAMA online manuscript submission and review system at http://manuscripts.jama.com (note: do not include "www" before the URL). At the time
of submission, complete contact information (postal/mail address, e-mail address,
telephone and fax numbers) for the corresponding author is required. First
and last names, e-mail addresses, and institutional affiliations of all co-authors
are also required. Manuscripts submitted through the online system should
not also be submitted by mail or e-mail. After the manuscript is submitted
online, the corresponding author will receive a manuscript number. Each author
should complete an authorship form and submit the completed form by regular
mail or fax. Please include the manuscript number on the authorship form in
the space provided. See Manuscript Checklist, Authorship Form, Manuscript Preparation and Submission Requirements,1,2 and other details in these instructions
for additional requirements.
Editorial Office Contact Information. JAMA,
515 N State St, Chicago, IL 60610, USA; telephone: (312) 464-4444 or (312)
464-2402; fax: (312) 464-5824; e-mail: firstname.lastname@example.com.
JAMA-EXPRESS.JAMA-EXPRESS provides rapid peer review and publication
of major clinical trials and other original research
studies that have immediate or public health importance.3 Authors who wish to have manuscripts considered for JAMA-EXPRESS should send the manuscript file and a request
letter to firstname.lastname@example.com or call (312) 464-2402.
Authors will be notified promptly whether the manuscript is approved for rapid
peer review. Authors of those manuscripts determined not to qualify for JAMA -Express may be invited to submit the manuscript for further consideration
under the standard review process.
JAMA publishes original contributions, reviews,
brief reports, special communications, commentaries, and many other categories
of articles. Topics of interest include all subjects that relate to the practice
of medicine and the betterment of public health worldwide. The most frequently
published types of articles are described herein.
Original Contribution. These reports typically
include randomized trials (see Clinical Trial below), intervention studies,
cohort studies, case-control studies, epidemiologic assessments, other observational
studies, surveys with high response rates (see Survey Research on page 122,
cost-effectiveness analyses and decision analyses (for more information see
page 126), and studies of screening and diagnostic tests (see also Reports
of Diagnostic Tests on page 126). Each manuscript should clearly state an
objective or hypothesis; the design and methods (including the study setting
and dates, patients or participants with inclusion and exclusion criteria
and/or participation or response rates, or data sources, and how these were
selected for the study); the essential features of any interventions; the
main outcome measures; the main results of the study; a comment section placing
the results in context with the published literature and addressing study
limitations; and the conclusions. Data included in research reports should
be as timely and current as possible (see Timeliness of Data on page 122.
A structured abstract is required; for more information, see instructions
for preparing structured abstracts on page 124. Recommended length: 3000-3500
words (not including abstract, tables, figures, and references).
Clinical Trial. In these studies, individuals
are randomly allocated to receive or not receive a preventive, therapeutic,
or diagnostic intervention and then followed up to determine the effect of
the intervention. All randomized clinical trials should include a flow diagram,
and authors should provide a completed randomized trial checklist and a trial
protocol. As of September 13, 2005, trials should be registered in a public
registry. (These and other requirements are detailed in Reports of Clinical
Trials on page 126). Each manuscript should clearly state an objective or
hypothesis; the design and methods (including the study setting and dates,
patients or participants with inclusion and exclusion criteria, or data sources,
and how these were selected for the study); the essential features of any
interventions; the main outcome measures; the main results of the study; a
comment section placing the results in context with the published literature
and addressing study limitations; and the conclusions. A structured abstract
is required; trial registration information (name, number, and URL) should
be listed at the end of the abstract (for more information, see instructions
for preparing structured abstracts on page 124). Recommended length: 3000-3500
words (not including abstract, tables, figures, and references).
Systematic Review (Including Meta-analysis). These
articles are systematic, critical assessments of literature and data sources
pertaining to clinical topics, emphasizing factors such as cause, diagnosis,
prognosis, therapy, or prevention. All articles or data sources should be
searched for and selected systematically for inclusion and critically evaluated,
and the search and selection process should be described in the paper. The
specific type of study or analysis, population, intervention, exposure, and
tests or outcomes should be described for each article or data source. The
article data sources should be as current as possible, ideally with the search
having been conducted within several months of manuscript submission. Meta-analyses
also will be considered as reviews.1(pp528-529) Authors of meta-analyses are encouraged to follow the instructions
provided in Reports of Meta-analyses on page 126. A structured abstract is
required; for more information, see instructions for preparing structured
abstracts on page 124. Recommended length: 3000-4000 words (not including
abstract, tables, figures, and references).
Caring for the Critically Ill Patient. Articles
published in this section are primarily original research reports, preferably
clinical trials, or systematic reviews (see above classifications for manuscript
submission requirements by category of article) that address virtually any
aspect of critical illness, from prevention and triage, through resuscitation
and acute treatment, to rehabilitation and palliation. Articles that provide
new insights into the diagnosis, prognosis, and treatment of critically ill
patients, as well as those that explore pathophysiological, technological,
ethical, or other related aspects of critical care medicine, are welcome.
For reports of original data and systematic reviews, a structured abstract
is required; see instructions for preparing structured abstracts on page 124.
Recommended length: 3000 to 3500 words (not including abstract, tables, figures,
and references).
Brief Report. These manuscripts are short reports
of original studies or evaluations or unique, first-time reports of clinical
case series. A structured abstract is required; for more information, see
instructions for preparing structured abstracts on page 124. Recommended length:
1000-1500 words (not including abstract, tables, figures, and references).
Special Communication. These manuscripts describe
an important issue in clinical medicine, public health, health policy, or
medical research in a scholarly, thorough, well-referenced, systematic or
evidence-based manner. A narrative (unstructured) abstract of 200 words or
fewer is required. Recommended length: up to 3000 words (not including tables,
figures, or references).
Commentary. These papers may address virtually
any important topic in medicine, public health, research, or health policy
and generally are not linked to a specific article. Commentaries should be
well focused, scholarly, and clearly presented. Recommended length: 1500-2000
words, with 1 table or figure, and approximately 20 references.
A Piece of My Mind. Most essays published in
A Piece of My Mind are personal vignettes (eg, exploring the dynamics of the
patient-physician relationship) taken from wide-ranging experiences in medicine;
occasional pieces express views and opinions on the myriad controversial issues
that affect the profession. Length limit: 1800 words.
Letter to the Editor. Letters discussing a
recent JAMA article will have the best chance of
acceptance if they are received within 4 weeks of the article's publication.
They should not exceed 400 words of text and 5 references; letters not meeting
these specifications are generally not considered. They should be double-spaced
and a word count should be provided. The text of letters should include the
names, academic degrees, and primary institutional affiliations for all authors,
and the e-mail address for the corresponding author. Letters must not duplicate
other material published or submitted for publication and should not include
unpublished data. Letters will be published at the discretion of the editors
and are subject to abridgement and editing for style and content.
Research Letter. Research Letters reporting
original research should not exceed 600 words of text and 6 references and
may include a table or figure. Letters must not duplicate other material published
or submitted for publication. In general, Research Letters should be divided
into the following sections: To the Editor (which serves as an introduction),
Methods, Results, and Comment. They should be double-spaced and a word count
should be provided with each letter. They should not include an abstract,
but otherwise should follow all of the guidelines in Manuscript Preparation
and Submission. Research letters considered for publication undergo external
peer review.
The following categories of articles require a presubmission inquiry
and discussion with an editor:
Clinical Review. These review articles address
a specific question or issue that is relevant for clinical practice and provide
an evidence-based, balanced, patient-oriented review on a focused topic. Clinical
reviews should include the clinical question or issue and its importance for
general medical practice, specialty practice, or public health; description
of how the relevant evidence was identified, assessed for quality, and selected
for inclusion; synthesis of the available evidence such that the best-quality
evidence (eg, well-conducted clinical trials, meta-analyses, and prospective
cohort studies) should receive the greatest emphasis; and discussion of controversial
aspects and unresolved issues. A structured abstract is required; for more
information, see instructions for preparing structured abstracts on page 124.
Maximum length: 3000 words of text, with no more than a total of 4 tables
and/or figures and no more than 50 references. Authors interested in submitting
a Clinical Review manuscript should contact the editorial office prior to
manuscript preparation and submission by sending an e-mail to firstname.lastname@example.com.
Controversies. The Controversies section provides
a forum for debate, discussion, and examination of challenging issues and
difficult questions in clinical medicine, research, public health, or health
policy. The section uses a "view-counterview" or "point-counterpoint"
format, in which 2 articles address the topic or issue and present opposing
viewpoints or positions. Manuscripts should be well argued, cogent, and scholarly,
with appropriate documentation for scientific content and factual assertions.
Recommended length is 2000 words of text, with 20 to 25 references and a maximum
of 1 table or figure. Authors interested in submitting a paper for the Controversies
section should contact the editorial office prior to manuscript submission
by sending an e-mail to firstname.lastname@example.com.
Grand Rounds. These papers present a case-based
discussion of a clinically relevant topic. They are to a great extent a faithful
reproduction of the actual Grand Rounds presentation that was made by the
author. We recommend that the presentation be transcribed or taped to assist
the author in maintaining the realism of the presentation. Grand Rounds papers
begin with a case presentation or, preferably, an interview with the actual
patient who has the disease or condition under discussion. Following the case
summary, the topic is presented in the same way as it was at the actual "live"
Grand Rounds, addressing the available evidence on epidemiology, etiology,
clinical presentation and evaluation, and therapy, when appropriate. A narrative
(unstructured) abstract of 200 words or fewer is required. Maximum length:
3500 words, with no more than 50 references and no more than 4 tables and
figures. For a recent example see JAMA. 2004:292:1857-1861.
Authors interested in submitting a Grand Rounds presentation should contact
the editorial office prior to manuscript preparation and submission by sending
an e-mail to email@example.com.
Health Law and Ethics. These manuscripts discuss
important issues in law and/or ethics with implications for patient care or
physician practice and of general medical interest. The manuscript may report
original data, although more often is a scholarly, well-referenced and systematic
review of the topic. The manuscript content must be original, and manuscripts
derived from previously published material (for example, a law review article)
are not acceptable. For reports of original data and systematic reviews, a
structured abstract is required; see instructions for preparing structured
abstracts on page 124. For all other manuscripts, a narrative (unstructured)
abstract of 200 words or fewer is required. Recommended length: up to 4000
words (not including references or abstract). Authors interested in submitting
a Health Law and Ethics manuscript should contact the editorial office prior
to manuscript and submission by sending an e-mail to firstname.lastname@example.com.
On Call.JAMA On Call
is a peer-reviewed section devoted to postgraduate medical education and training.
It provides an ongoing forum for discourse on educational, professional, and
scientific topics of special relevance to residents and fellows. Topics of
interest include but are not limited to education and training, career development,
technology, international medicine, ethical and medicolegal concerns, psychosocial
issues, and historical perspectives. The manuscript content must be original
and may represent Original Contributions, systematic Reviews, or scholarly
Commentaries (see above classifications for manuscript submission and abstract
requirements by category of article). Manuscripts reporting original research
may be up to 3000 words (excluding abstract, references, tables or figures);
others should be limited to fewer than 2000 words. Manuscripts are subject
to internal review by the section editorial board, as well as external peer
review. Authors interested in submitting an On Call manuscript should contact
the editorial office prior to manuscript preparation and submission by sending
an e-mail to firstname.lastname@example.com.
Patient-Physician Relationship. Articles published
in this section are scholarly, clinically-relevant considerations of various
aspects of the patient-physician relationship and its importance in medical
care. These articles may be Original Contributions, Clinical Trials, Systematic
Reviews (in those cases meeting the JAMA requirements
for articles in those categories), or evidence-based essays dealing with a
topic important to the relationship between patients and physicians. (For
a recent example see JAMA. 2005;293:1100-1106.) For
reports of original data and systematic reviews, a structured abstract is
required; see instructions for preparing structured abstracts on page 124.
For all other manuscripts, a narrative (unstructured) abstract of 200 words
or fewer is required. Recommended length: 3000-4000 words. Authors interested
in submitting a Patient-Physician Relationship manuscript should contact the
editorial office prior to manuscript submission by sending an e-mail to firstname.lastname@example.com.
Poetry and Medicine. Poems may be submitted
by e-mail or as attachments to e-mail to email@example.com.
Review of Books, Journals, New Media. Reviews
of books, journals, and new media are invited by the editor and may be submitted
by e-mail or as attachments to e-mail to firstname.lastname@example.com.
Questions about any other categories of articles should be directed
to the editorial office.
Authorship Criteria and Contributions. Each
author should have participated sufficiently in the work to take public responsibility
for appropriate portions of the content. One or more authors should take responsibility
for the integrity of the work as a whole, from inception to published article.
Authorship credit should be based only on (1) substantial contributions to
conception and design, or acquisition of data, or analysis and interpretation
of data; and (2) drafting the article or revising it critically for important
intellectual content; and (3) final approval of the version to be published.
Conditions 1, 2, and 3 must all be met.1,2
All authors (ie, the corresponding author and each coauthor) must complete
and submit an authorship form with signed statements on (1) authorship responsibility,
criteria, and contributions, (2) financial disclosure, and (3) either copyright
transfer or federal employment.1(pp89-93) In addition, authors are required to identify their contributions to
the work described in the manuscript.
For reports of original data and systematic reviews, authors'
specific contributions will be published in the Acknowledgment. The authors
also must certify that the manuscript represents valid work and that neither
this manuscript nor one with substantially similar content under their authorship
has been published or is being considered for publication elsewhere (see also
Duplicate/Previous Publication or Duplicate Submission). Authors of manuscripts
reporting original data or systematic reviews must provide an access to data
statement from at least one named author, often the corresponding author (see
also Data Access and Responsibility). If requested, authors should be prepared
to provide the data or cooperate fully in obtaining and providing the data
on which the manuscript is based for examination by the editors or their assignees.
Acknowledgment. The corresponding author must
sign the Acknowledgment statement. See Authorship Form on page 127. The Acknowledgment should include the names,
affiliations, and specific contributions of all persons who have contributed
to the work reported in the manuscript (eg, data collection, analysis, writing
or editing assistance) but who do not fulfill authorship criteria, and also
indicate whether any compensation was received for such contributions. Authors
should obtain written permission from all individuals named in the Acknowledgment.1(pp96-97) All financial and material support
should be reported in the Acknowledgment section of the manuscript, along
with detailed information on the roles of each sponsor or funder (see also
Funding/Support and Role of Sponsor).
Corresponding Author. If the manuscript is
accepted, the corresponding author (or coauthor designee) will serve on behalf
of all coauthors as the primary correspondent with the editorial office, to
review an edited typescript and proof in a timely manner, and to make decisions
regarding release of information in the manuscript to the news media, federal
agencies, or both, and will be identified as such in the published article.
Group Authorship. If authorship is attributed
to a group (either solely or in addition to 1 or more individual authors),
all members of the group must meet the full criteria and requirements for
authorship as described above.4 A group must
designate 1 or more individuals as authors or members of a writing group who
meet full authorship criteria and requirements. Other group members who are
not authors may be listed in an Acknowledgment.1(pp93-95)
Conflict of Interest. A conflict of interest
may exist when an author (or the author's institution or employer) has
financial or personal relationships that could inappropriately influence (or
bias) the author's decisions, work, or manuscript. All authors are required
to report potential conflicts of interest, including specific financial interests
relevant to the subject of their manuscript, in their cover letter and on JAMA's financial disclosure form or in an attachment
to the form. Authors without relevant financial interests in the manuscript
should indicate no such interest (see Authorship Form on page 127).5,6
Authors are required to report detailed information regarding all financial
and material support for the research and work, including but not limited
to grant support, funding sources, and provision of equipment and supplies.
Each author also is required to sign and submit the following financial disclosure
statement: "I certify that all my affiliations with or financial involvement,
within the past 5 years and foreseeable future (eg, employment, consultancies,
honoraria, stock ownership or options, expert testimony, grants or patents
received or pending, royalties) with any organization or entity with a financial
interest in or financial conflict with the subject matter or materials discussed
in the manuscript are completely disclosed."
Authors are expected to provide detailed information about any relevant
financial interests or financial conflicts within the past 5 years and for
the foreseeable future, particularly those present at the time the research
was conducted and up to the time of publication, as well as other financial
interests, such as relevant filed or pending patents or patent applications
in preparation, that represent potential future financial gain. Although many
universities and other institutions and organizations have established policies
and thresholds for reporting financial interests and other conflicts of interest, JAMA requires complete disclosure of all relevant financial
relationships and potential financial conflicts of interest, regardless of
amount or value. If authors are uncertain about what might constitute a potential
financial conflict of interest, they should err on the side of full disclosure
and should contact the editorial office if they have questions or concerns.
In addition, authors who have no relevant financial interests are asked to
provide a statement indicating that they have no financial interests related
to the material in the manuscript.
This information is for the editorial office and is not shared with
peer reviewers. However, for all accepted manuscripts, each author's
disclosures of relevant financial interests and declarations of no relevant
financial interests will be published. Decisions about whether financial information
provided by authors should be published, and thereby disclosed to readers,
are usually straightforward. Although editors are willing to discuss disclosure
of specific financial information with authors, JAMA's
policy is one of complete disclosure of all relevant financial interests.
The policy requesting disclosure of conflicts of interest applies for
all manuscript submissions, including letters to the editor and book reviews.
Funding/Support and Role of Sponsor. All financial
and material support for the research and the work should be clearly and completely
identified in an Acknowledgment. The specific role of the funding organization
or sponsor in each of the following should be specified: "design and
conduct of the study; collection, management, analysis, and interpretation
of the data; and preparation, review, or approval of the manuscript."5,6
Data Access and Responsibility. For all reports
(regardless of funding source) containing original data, at least 1 author
(eg, the principal investigator) who is independent of any commercial funder
should indicate that she or he "had full access to all the data in the
study and takes responsibility for the integrity of the data and the accuracy
of the data analysis."5 For industry-sponsored
studies, this statement must be provided by an investigator who is not employed
by any commercial funder, and an independent data analysis must be conducted
by statisticians at an academic institution with access to the raw data set,
rather than only by statisticians employed by the company sponsoring the research.
Details of this independent statistical analysis, the name and institutional
affiliation of the independent statistician, and whether compensation or funding
was received for conducting the analyses should be reported in the Acknowledgment.6
Duplicate/Previous Publication or Submission. Manuscripts
are considered with the understanding that they have not been published previously
in print or electronic format and are not under consideration by another publication
or electronic medium. Copies of related or possibly duplicative materials
(ie, those containing substantially similar content or using the same or similar
data) that have been previously published or are under consideration elsewhere
must be provided at the time of manuscript submission.1(pp98-102)
Timeliness of Data. Data included in research
reports submitted to JAMA should be as timely and
current as possible.7 Manuscripts based on
data from randomized controlled trials should be reported as soon as possible
after the trial has ended, ideally within 1 year after follow-up has been
completed. For cohort studies, the date of final follow-up should be no more
than 3 to 4 years before manuscript submission. Likewise, data used in case-control
or cross-sectional studies should have been collected as recently as possible,
but certainly less than 3 to 4 years ago. Authors of manuscripts that report
data that have been collected more than 4 years ago should provide an explanation
regarding the relevance of the information in light of current knowledge and
medical practice.
Survey Research. Manuscripts reporting survey
data, such as studies involving patients, clinicians, the public, or others,
should report data collected as recently as possible, ideally within the past
2 years.7 Survey studies should have sufficient
response rates (generally at least 60%) and appropriate characterization of
nonresponders to ensure that nonresponse bias does not threaten the validity
of the findings. For most surveys, such as those conducted by telephone, personal
interviews (eg, drawn from a sample of households), mail, e-mail, or via the
Web, authors are encouraged to report the survey outcome rates using standard
definitions and metrics, as proposed by the American Association for Public
Opinion Research.8
Reporting Race/Ethnicity. If race and/or ethnicity
is reported, indicate who classified individuals as to race/ethnicity, the
classifications, and whether the options were defined by the investigator
or the participant. Explain why race and/or ethnicity was assessed in the
Ethical Approval of Studies and Informed Consent. For human or animal experimental investigations, appropriate institutional
review board approval is required and should be so stated.1(p140) For those investigators who do not have formal ethics review
committees, the principles outlined in the Declaration of Helsinki should
be followed.10 For investigations of human
subjects, state in the Methods section the manner in which informed consent
was obtained from the study participants (ie, oral or written).
Identification of Patients in Descriptions, Photographs,
and Pedigrees. A signed statement of informed consent to publish (in
print and online) patient descriptions, photographs, and pedigrees should
be obtained from all persons (parents or legal guardians for minors) who can
be identified (including by the patients themselves) in such written descriptions,
photographs, or pedigrees and should be submitted with the manuscript. Such
persons should be shown the manuscript before its submission.1(pp141-142) Omitting data or making data less specific to deidentify
patients is acceptable but changing any such data are not acceptable. See patient
permission form.
Personal Communications and Unpublished Data. A
signed statement of permission should be included from each individual identified
as a source of information in a personal communication or as a source for
unpublished data, and the date of communication and whether the communication
was written or oral should be specified.1(p125)
Previous Presentation or Release of Information. A
complete report following presentation at a meeting or publication of preliminary
findings elsewhere (eg, an abstract) can be considered. Media coverage of
meeting presentations will not jeopardize consideration, but direct release
of information through press releases or news media briefings may preclude
consideration by JAMA.11 Rare
instances of papers reporting public health emergencies should be discussed
with the editor. Authors submitting manuscripts or letters to the editor regarding
adverse drug or medical device reactions, reportable diseases, etc, should
also report such to the relevant government agency.
Embargo Policy. All information regarding the
content and publication date of accepted manuscripts is strictly confidential.
Information contained in or about accepted articles cannot appear in print,
on radio or television, or in electronic form or be released by the news media
until 3 PM Central Time on Tuesday, the day before its publication
date (or other specified embargo release date for the rare cases in which
articles are released early).11
Unauthorized Use. Published manuscripts become
the permanent property of the American Medical Association (AMA) and may not
be published elsewhere without written permission. Unauthorized use of the JAMA name, logo, or any content for commercial purposes
or to promote commercial goods and services (in any format, including print,
video, audio, and digital) is not permitted by JAMA or
the AMA.
Authors will be sent notifications of the receipt of manuscripts and
editorial decisions by e-mail. During the review process, authors can check
the status of their submitted manuscript via the online manuscript submission
and review system (http://manuscripts.jama.com).
JAMA receives more than 5000 papers each year
and publishes about 7% of unsolicited manuscripts. For additional information
see JAMA. 2005;293:1123.12
Manuscripts should meet the following criteria: material is original;
writing is clear; study methods are appropriate; data are valid; conclusions
are reasonable and supported by the data; information is important; and topic
has general medical interest. From these basic criteria, the editors assess
a paper's eligibility for publication.
Editorial and Peer Review. All submitted manuscripts
are reviewed initially by a JAMA editor. Manuscripts
with insufficient priority for publication are rejected promptly. Other manuscripts
are sent to expert consultants for peer review. Peer reviewer identities are
kept confidential, but author identities are made known to reviewers. The
existence of a manuscript under review is not revealed to anyone other than
peer reviewers and editorial staff. Information from submitted manuscripts
may be systematically collected and analyzed as part of research to improve
the quality of the editorial or peer review process. Identifying information
remains confidential.
Editing. Accepted manuscripts are edited in
accordance with the American Medical Association Manual
of Style1 and returned to the author
for approval. Authors are responsible for all statements made in their work,
including changes made by the manuscript editor and authorized by the corresponding
Reprints. Reprint order forms are included
with the edited typescript sent for approval to the corresponding author.
Reprints ship 2 weeks after publication.
ePrints. Corresponding authors who provide
an e-mail address for publication will receive an electronic link that provides
25 free online accesses to the PDF view of their article.
Manuscripts should be prepared in accordance with the American Medical Association Manual of Style1 and/or
the Uniform Requirements for Manuscripts Submitted to Biomedical Journals.2
Cover Letter. Include a cover letter and complete
contact information for the corresponding author (postal/mail address, e-mail
address, and telephone and fax numbers) and whether the authors have published
or submitted any related papers from the same study (see Duplicate/Previous
Publication or Submission on page 122).
Manuscript Components. Include a title page,
abstract, text, references, and as appropriate, figure legends, tables, and
figures. Start each of these sections on a new page, numbered consecutively,
beginning with the title page.
Recommended File Sizes. We recommend individual
file sizes of no more than 500 KB and not exceeding 1 MB, with the total size
for all files not exceeding 5 MB (not including any video files).
Manuscript File Formats. For submission and
review, acceptable manuscript file formats include Word, WordPerfect, PDF,
EPS, Text, Postscript, or RTF format. However, if the manuscript is accepted
for publication, a PDF text file cannot be used and authors will be asked
to send it in Word or WordPerfect format.
Use 10-, 11-, or 12-point font size, double-space text, and leave right
margins unjustified (ragged).
Line numbers on each page of text are also helpful for reviewers.
Title Page. The title page should include a
word count for text only and the full names, highest academic degrees, and
affiliations of all authors. If an author's affiliation has changed
since the work was done, the new affiliation also should be listed.
Abstract. Include a structured abstract of
no more than 300 words for reports of original data, reviews and, meta-analyses.
(See instructions for preparing structured abstracts on this page) For other
major manuscripts, include an unstructured abstract of no more than 200 words
that summarizes the objective, main points, and conclusions of the article.
Abstracts are not required for editorials, commentaries, and some special
Abbreviations. Do not use abbreviations in
the title or abstract and limit their use in the text. Expand all abbreviations
at first mention in the text.
Units of Measure. Conventional units of measure
are preferred, with Système International (SI) units expressed secondarily
(in parentheses). In tables and figures, a conversion factor to SI may be
presented in the footnote or legend to economize space. Exceptions to this
policy include calories, hematocrit, glycosylated hemoglobin, blood cell counts,
and ejection fraction, for which conventional units alone should be expressed.
The metric system is preferred for the expression of length, area, mass, and
volume. For more details, see SI unit conversion table.
Names of Drugs, Devices, and Other Products. Use
nonproprietary names of drugs, devices, and other products, unless the specific
trade name of a drug is essential to the discussion.1(pp355-356)
Gene Names and Symbols. Consult the Human Genome
Organisation Gene Nomenclature Committee site for gene names and symbols (http://www.gene.ucl.ac.uk/nomenclature).
Reproduced Material.JAMA does not republish text, tables, figures, or other material from other
publishers, except under rare circumstances. Please delete any such material
and replace with originals.
References. Authors are responsible for the
accuracy and completeness of their references and for correct text citation.
Number references in the order they appear in the text; do not alphabetize.
In text, tables, and legends, identify references with superscript arabic
numerals. When listing references, follow AMA style1(pp28-51) and abbreviate names of journals according to Index Medicus. Note: List all authors and/or editors up to 6; if more
than 6, list the first 3 followed by "et al."
Examples of Reference Style:
1. Carrat F, Bani-Sadr F, Pol S, et al; for
the ANRS HCO2 RIBAVIC Study Team. Pegylated interferon alfa-2b vs standard
interferon alfa-2b, plus ribavirin, for chronic hepatitis C in HIV-infected
patients: a randomized controlled trial. JAMA. 2004;292:2839-2848.
2. Dybul M, Connors M, Fauci AS. Immunology
of HIV infection. In: Paul WE, ed. Fundamental Immunology. 5th ed. Philadelphia, Pa: Lippincott Williams & Wilkins; 2003:1285-1318.
3. The key and critical objectives of JAMA. Available at: http://jama.ama-assn.org/about_current.dtl. Accessed January 5, 2005.
Tables. Number all tables in the order of their
citation in the text. Include a title for each table (a brief phrase, preferably
no longer than 10 to 15 words). Include all tables in a single file following
the manuscript. Refer to Categories of Articles as there may be a limit on
the number of tables for the type of manuscript. If a table must be continued,
repeat the title on a second sheet, followed by "(cont)." See Instructions
for Table Creation.
Figures. Number all figures (graphs, charts,
photographs, and illustrations) in the order of their citation in the text.
Include a title for each figure (a brief phrase, preferably no longer than
10 to 15 words).
For initial manuscript submissions, figures must be of sufficient quality
for editorial assessment and peer review. Please note, however, if the manuscript
is accepted, authors will be asked to provide figures that meet the Guidelines for Figures in Accepted Manuscripts. All graphs, charts,
illustrations, titles, and legends of accepted manuscripts will be re-created
or edited according to JAMA style and standards prior
to publication.
Acceptable Figure File Size: To reduce the
time that it takes to upload files to the JAMA submission
site and for reviewers to download files from the site, we recommend that
the file size of figures be compressed before uploading them. This can be
done by using compression software or by decreasing the resolution of individual
Acceptable Figure File Formats: At submission,
the following file formats are acceptable: AI, BMP, DOC, EMF, EPS, JPG, PDF,
PPT, PSD, TIF, WMF, or XLS. Figures may be embedded at the end of the manuscript
text file or loaded as separate files for submission purposes.
Figure Legends (Captions): Include a legend
for each photograph, graph, and illustration at the end of the manuscript
(maximum length, 40 words). For photomicrographs, include the type of specimen,
original magnification or a scale bar, and stain. For gross pathology specimens,
label any rulers with unit of measure.
Number of Figures: Refer to Categories of Articles
as there may be a limit on the number of figures for the type of manuscript.
Video. Video file formats acceptable at submission
are MOV, AVI, MPEG, RM, and WM, and the file size should not exceed 5 MB with
a maximum dimension of 800 pixels wide and/or 600 pixels deep.
All reports of original data, systematic reviews and meta-analyses,
and clinical reviews should be submitted with structured abstracts as described
below. No information should be reported in the abstract that does not appear
in the text of the manuscript. The following is adapted from "More informative
abstracts revisited."13
Reports of Original Data. Reports of original
data should include an abstract of no more than 300 words using the following
headings: Context, Objective, Design, Setting, Patients (or Participants),
Interventions (include only if there are any), Main Outcome Measure(s), Results,
and Conclusions. For brevity, parts of the abstract may be written as phrases
rather than complete sentences. Each section should include the following
Context: The abstract should begin with a sentence
or 2 explaining the clinical (or other) importance of the study question.
Objective: State the precise objective or study
question addressed in the report (eg, "To determine whether . . . ").
If more than 1 objective is addressed, the main objective should be indicated
and only key secondary objectives stated. If an a priori hypothesis was tested,
it should be stated.
Design: Describe the basic design of the study.
State the years of the study and the duration of follow-up. If applicable,
include the name of the study (eg, the Framingham Heart Study).
Setting: Describe the study setting to assist
readers to determine the applicability of the report to other circumstances,
for example, general community, a primary care or referral center, private
or institutional practice, or ambulatory or hospitalized care.
Patients or Other Participants: State the clinical
disorders, important eligibility criteria, and key sociodemographic features
of patients. The numbers of participants and how they were selected should
be provided (see below), including the number of otherwise eligible individuals
who were approached but refused. If matching is used for comparison groups,
characteristics that are matched should be specified. In follow-up studies,
the proportion of participants who completed the study must be indicated.
In intervention studies, the number of patients withdrawn because of adverse
effects should be given. For selection procedures, these terms should be used,
if appropriate: random sample (where random refers to a formal, randomized
selection in which all eligible individuals have a fixed and usually equal
chance of selection); population-based sample; referred sample; consecutive
sample; volunteer sample; convenience sample.
Intervention(s): The essential features of
any interventions should be described, including their method and duration
of administration. The intervention should be named by its most common clinical
name, and nonproprietary drug names should be used.
Main Outcome Measure(s): Indicate the primary
study outcome measurement(s) as planned before data collection began. If the
manuscript does not report the main planned outcomes of a study, this fact
should be stated and the reason indicated. State clearly if the hypothesis
being tested was formulated during or after data collection.
Results: The main outcomes of the study should
be provided and quantified, including confidence intervals (for example, 95%)
or P values. For comparative studies, the differences
between groups should be expressed with confidence intervals. Explain outcomes
or measurements unfamiliar to a general medical readership. Important measurements
not presented in results should be declared. As relevant, indicate whether
observers were blinded to patient groupings, particularly for subjective measurements.
If differences for the major study outcome measure(s) are not significant,
the clinically important difference sought should be stated and the confidence
interval for the difference between the groups should be given. When risk
changes or effect sizes are given, absolute values should be indicated. Approaches
such as number needed to treat to achieve a unit of benefit are encouraged
when appropriate; reporting of relative differences alone is insufficient.
Studies of screening and diagnostic tests should report sensitivity, specificity,
and likelihood ratio. If predictive value or accuracy is given, prevalence
or pretest likelihood should be given as well. All randomized controlled trials
should include the results of intention-to-treat analysis, and all surveys
should include response rates.
Conclusions: Provide only conclusions of the
study directly supported by the results, along with implications for clinical
practice, avoiding speculation and overgeneralization. Indicate whether additional
study is required before the information should be used in usual clinical
settings. Give equal emphasis to positive and negative findings of equal scientific
Trial Registration: For clinical trials, provide
the name of the trial registry, registration number, and URL of the registry.
Systematic Reviews/Meta-analyses. Manuscripts
reporting the results of meta-analyses should include an abstract of no more
than 300 words using the following headings: Context, Objective, Data Sources,
Study Selection, Data Extraction, Data Synthesis, and Conclusions. The text
of the manuscript should also include a section describing the methods used
for data sources, study selection, data extraction, and data synthesis. Each
heading should be followed by a brief description:
Context: A sentence or 2 explaining the importance
of the review question.
Objective: State the precise primary objective
of the review. Indicate whether the review emphasizes factors such as cause,
diagnosis, prognosis, therapy, or prevention and include information about
the specific population, intervention, exposure, and tests or outcomes that
are being reviewed.
Data Sources: Succinctly summarize data sources,
including years searched. The search should include the most current information
possible, ideally with the search being conducted within several months before
the date of manuscript submission. Potential sources include computerized
databases and published indexes, registries, abstract booklets, conference
proceedings, references identified from bibliographies of pertinent articles
and books, experts or research institutions active in the field, and companies
or manufacturers of tests or agents being reviewed. If a bibliographic database
is used, state the exact indexing terms used for article retrieval, including
any constraints (for example, English language or human subjects). If abstract
space does not permit this level of detail, summarize sources in the abstract
including databases and years searched, and place the remainder of the information
in the Methods section.
Study Selection: Describe inclusion and exclusion
criteria used to select studies for detailed review from among studies identified
as relevant to the topic. Details of selection should include particular populations,
interventions, outcomes, or methodological designs. The method used to apply
these criteria should be specified (for example, blinded review, consensus,
multiple reviewers). State the proportion of initially identified studies
that met selection criteria.
Data Extraction: Describe guidelines used for
abstracting data and assessing data quality and validity (such as criteria
for causal inference). The method by which the guidelines were applied should
be stated (for example, independent extraction by multiple observers).
Data Synthesis: State the main results of the
review, whether qualitative or quantitative, and outline the methods used
to obtain these results. Meta-analyses should state the major outcomes that
were pooled and include odds ratios or effect sizes and, if possible, sensitivity
analyses. Numerical results should be accompanied by confidence intervals,
if applicable, and exact levels of statistical significance. Evaluations of
screening and diagnostic tests should include sensitivity, specificity, likelihood
ratios, receiver operating characteristic curves, and predictive values. Assessments
of prognosis should summarize survival characteristics and related variables.
Major identified sources of variation between studies should be stated, including
differences in treatment protocols, co-interventions, confounders, outcome
measures, length of follow-up, and dropout rates.
Conclusions: The conclusions and their applications
(clinical or otherwise) should be clearly stated, limiting interpretation
to the domain of the review.
Clinical Reviews. Clinical Review articles
should include an abstract of no more than 250 words with the following sections:
Context, Evidence Acquisition, Evidence Synthesis, and Conclusions.
Context: Include 1 or 2 sentences describing
the clinical question or issue and its importance in clinical practice or
public heath.
Evidence Acquisition: Describe the data sources
used, including the search strategies, years searched, and other sources of
material, such as subsequent reference searches of retrieved articles. Methods
used for quality assessment and inclusion of identified articles should be
Evidence Synthesis: The major findings of the
review of the clinical issue or topic should be addressed in an evidence-based,
objective, and balanced fashion, with the highest quality evidence available
receiving the greatest emphasis.
Conclusions: The conclusions should clearly
answer the questions posed if applicable, be based on available evidence,
and emphasize how clinicians should apply current knowledge.
Manuscripts reporting the results of randomized controlled trials (RCTs)
should include the CONSORT flow diagram showing the progress of patients throughout
the trial (see Figure). The
CONSORT checklist
also should be completed and submitted with the manuscript.14
Protocols. Authors of RCTs are also encouraged
to submit trial protocols along with their manuscripts.
Trial Registration. As a member of the International
Committee of Medical Journal Editors (ICMJE), JAMA will
require, as a condition of consideration for publication, registration of
all trials in a public trials registry that requires the minimum registration
data set as determined by the World Health Organization and the ICMJE.2,15,16 Trials must be
registered at or before the onset of patient enrollment. This policy applies
to any clinical trial starting enrollment after July 1, 2005. For trials that
began enrollment before this date, registration will be required by September
13, 2005, before considering the trial for publication. For this purpose,
the ICMJE defines a clinical trial as any study that prospectively assigns
human subjects to intervention or comparison groups to evaluate the cause-and-effect
relationship between a medical intervention and a health outcome. Studies
designed for other purposes, such as to study pharmacokinetics or major toxicity
(eg, phase 1 trials), are exempt. The trial registry name, registration number,
and the URL for the registry should be included at the end of the abstract.
Reports of Diagnostic Tests. Authors of reports
of diagnostic tests are encouraged to submit the STARD flow diagram and checklist
(for more information, see Clin Chem. 2003;49:1-6,
7-18 or http://www.clinchem.org/cgi/content/full/49/1/1).
Reports of Meta-analyses. Authors of reports
of meta-analyses of randomized trials are encouraged to submit the QUOROM
flow diagram and checklist (http://www.consort-statement.org/QUOROM.pdf). Authors of meta-analyses of observational studies are encouraged
to submit the MOOSE checklist (http://www.consort-statement.org/MOOSE.pdf).
Reports of Cost-effectiveness Analyses and Decision
Analyses. Authors of reports of cost-effectiveness analyses and decision
analyses must submit a copy of the decision tree comprising their model. This
is for editorial evaluation and review, not for publication, unless it is
included in the body of the manuscript itself.
□ 1. Review manuscript submission
instructions on our Web-based submission and review system (http://manuscripts.jama.com).
□ 2. Include a cover letter as
an attachment.
□ 3. Designate a corresponding
author and provide a complete postal/mail address, telephone and fax numbers,
and e-mail address.
□ 4. Provide first and last names,
e-mail addresses, and institutional affiliations for any coauthors.
□ 5. On the title page, include
a word count for text only, exclusive of title, abstract, references, tables,
and figure legends.
□ 6. Provide an abstract that
conforms to the required abstract format.
□ 7. Double-space manuscript and
leave right margins unjustified (ragged).
□ 8. Check all references for
accuracy and completeness. Put references in proper format in numerical order,
making sure each is cited in sequence in the text.
□ 9. Include a title for each
table and figure (a brief, succinct phrase, preferably no longer than 10 to
15 words) and explanatory legend as needed.
□ 10. Have each author read, complete,
and sign the Authorship Form with statements of authorship responsibility, criteria,
and contributions; financial disclosure; and copyright transfer. After submission,
add the manuscript number to the top of each author form and send in the author
forms by mail or fax to the editorial office.
□ 11. Indicate specific contributions
from each author (see authorship checklist on Authorship Form).
□ 12. Include statement signed by corresponding author that written permission has
been obtained from all persons named in the Acknowledgment.
□ 13. For reports of original data,
include statement from at least 1 author that she or he "had full access
to all of the data in the study and takes responsibility for the integrity
of the data and the accuracy of the data analysis."
□ 14. Include research or project
support/funding in the Acknowledgment.
□ 15. Also in the Acknowledgment,
specify the role of the funder(s) or sponsor(s) in each of the following:
design and conduct of the study; collection, management, analysis, and interpretation
of the data; and preparation, review, or approval of the manuscript.
□ 16. Include written permission
from each individual identified as a source for personal communication or
unpublished data.
□ 17. If appropriate, include information
on institutional review board/ethics committee approval or waiver and informed
□ 18. Reprinted tables and figures
are discouraged. Original material should be provided, except under extraordinary
□ 19. Include informed consent forms for identifiable patient descriptions, photographs,
and pedigrees.
Some tools below are only available to our subscribers or users with an online account.
Download citation file:
Customize your page view by dragging & repositioning the boxes below.
More Listings atJAMACareerCenter.com >
Enter your username and email address. We'll send you a link to reset your password.
Enter your username and email address. We'll send instructions on how to reset your password to the email address we have on record.
Need assistance?
Athens and Shibboleth are access management services that provide single sign-on to protected resources. They replace the multiple user names and passwords necessary to access subscription-based content with a single user name and password that can be entered once per session. It operates independently of a user's location or IP address. If your institution uses Athens or Shibboleth authentication, please contact your site administrator to receive your user name and password.


text:
Nassau Man Shot By Police; Wife Found Dead In Home
A Long Island man was wounded in a shootout with police Thursday outside a Hempstead home where his wife was found dead and another woman was injured, police said.
The man, identified by police as Lenny Reed, opened fire on four Hempstead Village Police officers who responded to a report of a disturbance at 25 Roosevelt St., police said.
The shootout lasted until officers shot Reed on the side of the chest and arrested him, police said. The suspect was taken to Nassau University Medical Center. Police said charges against him were pending.
When officers entered the home, they found the body of Reed's wife, police said. They declined to say how she had been killed.
Another woman was found with a gunshot wound to her chest and taken to Nassau University Medical Center, authorities said.
No police were injured in the shootout.
The victim's longtime friend Keith Burgess said the couple had been separated for a time although they remained married, he said.
Burgess said the injured woman was Reed's cousin, who rented the basement of the house.
Police declined to identify the victims.
Witnesses described seeing officers converge outside the house and duck behind cars during the shootout.
"We just heard a whole lot of gunfire, and you knew it was gunfire," said Jessica Jones, 45, who lives nearby said she and went to high school with the victim.
Burgess said the victim had an 18-year-old daughter and had been married to Reed for three or so years.
"This is so devastating I'm at a loss for words," he said.


text:
Groups around the state are talking about transportation funding but a new poll shows voters may not be ready to approve a tax backing the state's highway system.
In a recent survey of more than 1,000 voters, nearly half of respondents said they would describe the quality of the state's roads and bridges as excellent or good, and less than 33 percent are willing to pay an additional 5 cents or more for gasoline to improve Colorado's transportation system.
The news is discouraging for officials and government groups interested in taking a gas or sales tax increase question to boost funding for the cash-strapped Colorado Department of Transportation to voters in the foreseeable future.
"A huge percentage of Coloradans already think that our roads are decent," said Dan Gibbs, Summit County Commissioner and chair of the Colorado Counties Inc. transportation committee. "You're not starting at a good spot if people don't think there's a problem."
CDOT's annual budget has fallen by approximately half a billion dollars in the last several years. The remainder is just enough to cover the on-going maintenance costs of Colorado's existing highway system, with little left for road upgrades, major improvements or what is most needed on the Interstate 70 mountain corridor - projects to increase capacity.
CDOT's primary revenue source, a 40 cent per gallon gas tax, has been stagnant for more than 20 years and its purchasing power has diminished by half in that timeframe.
"It's kind of a going-out-of-business model for state highway systems under the current funding mechanism," CDOT director Don Hunt told the Summit Daily News in a 2010 interview. "Colorado's going to grow from 5 million people to 7 million people, they say, by 2030. That's going to create more congestion. We don't have any money for new capacity."
The grim numbers have generated two conversations around funding models for future highway projects: taxes and tolls.
While CDOT officials have warned the public to expect the latter to be part of any future capacity expansion projects on I-70, other groups across the state - particularly those representing local governments, who under state statute, could get a cut of a transportation funding tax - are now talking about the first option.
But the possible return isn't significant for an agency that needs an additional $300 million per year just to stabilize existing roads.
If voters approved a 10-cent increase in the gas tax, and the poll indicates they likely wouldn't, the hike is expected to generate approximately $264 million dollars on average over the next 10 years, a portion of which would go to local cities and counties per state statute. CDOT's cut would be only $158 million.
Upwards of 65 percent of respondents to the poll, all of whom are voters, were willing to increase their annual taxes to improve Colorado's bridges and roads, they just preferred to see a sales tax increase, rather than a hike on gas taxes.
But the return on the floated 5 cent sales tax increase 58 percent of respondents said they would support would funnel only an additional $173 million into CDOT coffers annually.
Still, officials say the option of a ballot measure remains on the table.
"Just because it might not poll really high right now, doesn't mean that passing something is impossible," Gibbs said. "You have to educate people sometimes. You're just starting at a lower point."
CDOT officials say they are party to, but not the driving force, behind ballot question conversations.
"We're just an agency participating in these conversations," spokesman Bob Wilson said. "We're not heading up the effort."